For example, SERPINH1 has been reported to be upregulated, and associated with poor prognosis in breast cancer, stomach adenocarcinoma (STAD), and esophageal carcinoma (ESCA) (Lee et al., 2016; Strack et al., 2020; and Yang et al., 2020). This evidence concerns the gene SERPINH1 and breast carcinoma.